These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
564 related articles for article (PubMed ID: 18619895)
1. High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas. Kidani K; Osaki M; Tamura T; Yamaga K; Shomori K; Ryoke K; Ito H Oral Oncol; 2009 Jan; 45(1):39-46. PubMed ID: 18619895 [TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus. Yamada A; Fujii S; Daiko H; Nishimura M; Chiba T; Ochiai A Int J Oncol; 2011 Feb; 38(2):345-53. PubMed ID: 21165554 [TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of EZH2 is associated with pathological findings and P53 alteration. Shiogama S; Yoshiba S; Soga D; Motohashi H; Shintani S Anticancer Res; 2013 Oct; 33(10):4309-17. PubMed ID: 24122997 [TBL] [Abstract][Full Text] [Related]
4. EZH2 promotes malignant phenotypes and is a predictor of oral cancer development in patients with oral leukoplakia. Cao W; Younis RH; Li J; Chen H; Xia R; Mao L; Chen W; Ren H Cancer Prev Res (Phila); 2011 Nov; 4(11):1816-24. PubMed ID: 21697275 [TBL] [Abstract][Full Text] [Related]
5. Role of EZH2 in oral squamous cell carcinoma carcinogenesis. Zhao L; Yu Y; Wu J; Bai J; Zhao Y; Li C; Sun W; Wang X Gene; 2014 Mar; 537(2):197-202. PubMed ID: 24424512 [TBL] [Abstract][Full Text] [Related]
6. Minichromosome maintenance-7 and geminin are reliable prognostic markers in patients with oral squamous cell carcinoma: immunohistochemical study. Tamura T; Shomori K; Haruki T; Nosaka K; Hamamoto Y; Shiomi T; Ryoke K; Ito H J Oral Pathol Med; 2010 Apr; 39(4):328-34. PubMed ID: 20136698 [TBL] [Abstract][Full Text] [Related]
7. Expression of Gα12 predicts progression and prognosis of oral squamous cell carcinomas in Taiwan. Cheng SJ; Liu YC; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Kuo MY; Chiang CP J Oral Pathol Med; 2013 Aug; 42(7):565-9. PubMed ID: 23438080 [TBL] [Abstract][Full Text] [Related]
8. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance. Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407 [TBL] [Abstract][Full Text] [Related]
9. Runt-related transcription factor 3 expression in human oral squamous cell carcinomas; implication for tumor progression and prognosis. Tanji Y; Osaki M; Nagahama Y; Kodani I; Ryoke K; Ito H Oral Oncol; 2007 Jan; 43(1):88-94. PubMed ID: 16798064 [TBL] [Abstract][Full Text] [Related]
10. Expression of RCAS1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. Tsai TC; Yu CH; Cheng SJ; Liu BY; Chen HM; Chiang CP Oral Oncol; 2008 Aug; 44(8):759-66. PubMed ID: 18061525 [TBL] [Abstract][Full Text] [Related]
11. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573 [TBL] [Abstract][Full Text] [Related]
12. High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy. He LR; Liu MZ; Li BK; Jia WH; Zhang Y; Liao YJ; Chen YC; Zhang LJ; Guan XY; Zeng YX; Kung HF; Xie D Int J Cancer; 2010 Jul; 127(1):138-47. PubMed ID: 19904743 [TBL] [Abstract][Full Text] [Related]
13. Decreased expression of Ep-CAM protein is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. Hwang EY; Yu CH; Cheng SJ; Chang JY; Chen HM; Chiang CP J Oral Pathol Med; 2009 Jan; 38(1):87-93. PubMed ID: 18355175 [TBL] [Abstract][Full Text] [Related]
14. Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer. Matsukawa Y; Semba S; Kato H; Ito A; Yanagihara K; Yokozaki H Cancer Sci; 2006 Jun; 97(6):484-91. PubMed ID: 16734726 [TBL] [Abstract][Full Text] [Related]
15. LncRNA PART1 promotes cell proliferation and inhibits apoptosis of oral squamous cell carcinoma by blocking EZH2 degradation. Yu Q; Du Y; Wang S; Zheng X J Biochem; 2021 Sep; 169(6):721-730. PubMed ID: 33725092 [TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor is significantly associated with progression and prognosis of oral squamous cell carcinomas in Taiwan. Cheng SJ; Lee JJ; Kok SH; Chou CH; Chang HH; Yang H; Chiang ML; Kuo MY J Formos Med Assoc; 2011 Jan; 110(1):50-7. PubMed ID: 21316013 [TBL] [Abstract][Full Text] [Related]
17. Cyclo-oxygenase-1 and -2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance. Shibata M; Kodani I; Osaki M; Araki K; Adachi H; Ryoke K; Ito H Oral Oncol; 2005 Mar; 41(3):304-12. PubMed ID: 15743693 [TBL] [Abstract][Full Text] [Related]
18. Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma. Cao W; Feng Z; Cui Z; Zhang C; Sun Z; Mao L; Chen W Cancer; 2012 Jun; 118(11):2858-71. PubMed ID: 21989926 [TBL] [Abstract][Full Text] [Related]
19. Increased expression of MCM5 is significantly associated with aggressive progression and poor prognosis of oral squamous cell carcinoma. Yu SY; Wang YP; Chang JY; Shen WR; Chen HM; Chiang CP J Oral Pathol Med; 2014 May; 43(5):344-9. PubMed ID: 24245508 [TBL] [Abstract][Full Text] [Related]
20. Enhancer of zeste homolog 2 expression is associated with tumor cell proliferation and metastasis in gastric cancer. Choi JH; Song YS; Yoon JS; Song KW; Lee YY APMIS; 2010 Mar; 118(3):196-202. PubMed ID: 20132185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]